Clinical trial
International Immune Tolerance Study
NCT00212472 · New York Presbyterian Hospital, Other · Terminated
Key facts
| NCT number | NCT00212472 |
|---|---|
| Title | International Immune Tolerance Study |
| Official title | An International Randomised Controlled Trial Of Immune Tolerance Induction |
| Lead sponsor | New York Presbyterian Hospital, Other |
| Collaborators | Manchester University NHS Foundation Trust |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Hemophilia A With Inhibitors |
| Intervention type | Drug, Other |
| Interventions | Factor VIII concentrates, Low-dose treatment, High-dose treatment |
| Enrollment | 134 |
| Start date | Jul 1, 2002 |
| Primary completion | Dec 1, 2010 |
| Completion | Dec 1, 2012 |
| First posted | Sep 21, 2005 |
| Last update posted | Dec 7, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: